← back to search

Ruiqi Liu

Huazhong University of Science and Technology · CN
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, and Ferroptosis and cancer prognosis.
h-index
25
citations
2,665
works
176
NIH funding
primary concept
email

Recent publications

Superstable lipid vacuoles endow cartilage with its shape and biomechanics
Science 2025cited by 21position: middledoi
GC-PGE: A novel deep learning model for tumor drug resistance prediction and core resistance gene extraction based on graph and signaling pathways
Computational Biology and Chemistry 2025cited by 1position: middledoi
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer
Clinical and Translational Medicine 2024cited by 45position: middledoi
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
Cancer Research 2024cited by 30position: middledoi
Dermal TRPV1 innervations engage a macrophage- and fibroblast-containing pathway to activate hair growth in mice
Developmental Cell 2024cited by 17position: middledoi
A “One Arrow Three Eagle” Strategy to Improve CM‐272 Primed Bladder Cancer Immunotherapy
Advanced Materials 2023cited by 35position: firstdoi
Association of <i>KMT2C/D</i> loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Cancer Science 2023cited by 30position: firstdoi
Fe/Ni layered double hydroxide biocatalysts inhibit tumor growth through ROS and ferroptosis signaling pathway
Chemical Engineering Journal 2023cited by 26position: middledoi
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail
Cancer Letters 2023cited by 23position: middledoi
ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization
BMC Medicine 2023cited by 20position: middledoi
A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma
Frontiers in Immunology 2023cited by 13position: firstdoi
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Journal for ImmunoTherapy of Cancer 2021cited by 243position: middledoi
RETRACTED: Phototherapy together with it triggered immunological response for Anti-HPV treatment of oropharyngeal cancer: Removing tumor and pathogenic virus simultaneously
Biomaterials 2021cited by 6position: middledoi
Retraction notice to “Phototherapy together with it triggered immunological response for Anti-HPV treatment of oropharyngeal cancer: Removing tumor and pathogenic virus simultaneously” [Biomaterials (2021) 120777]
Biomaterials 2021cited by 2position: middledoi
Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance
Cancer Research 2020cited by 138position: middledoi
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
Cancer Research 2019cited by 422position: middledoi
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
Theranostics 2019cited by 135position: middledoi
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
Cancer Letters 2018cited by 142position: firstdoi
Comprehensive Analysis of the Relationship Between RAS and RAF Mutations and MSI Status of Colorectal Cancer in Northeastern China
Cellular Physiology and Biochemistry 2018cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yanqiao Zhang · Zhejiang Provincial People's Hospital7 papers (2018–2024)Yuanfei Yao · Harbin Medical University6 papers (2021–2024)Bojun Wang · Ningbo University5 papers (2021–2024)Yuanyu Liao · Harbin Medical University5 papers (2023–2024)Xuefan Yu · Harbin Medical University4 papers (2023–2024)Zhi‐Xuan Li · Sun Yat-sen University3 papers (2019–2020)Lin Fang · Qingdao University3 papers (2021–2024)Jia‐Wei Lv · Zhejiang Chinese Medical University3 papers (2019–2020)Hongxue Meng · Harbin Medical University3 papers (2018–2021)Xinxin Yang · Guangzhou University of Chinese Medicine3 papers (2018–2021)Fo‐Ping Chen · Sun Yat-sen University3 papers (2019–2020)Zi‐Qi Zheng · Sun Yat-sen University3 papers (2019–2020)Guan‐Qun Zhou · Sun Yat-sen University3 papers (2019–2020)Xiaojun He · Harbin Medical University3 papers (2019–2020)Luying Cui · Ministry of Education of the People's Republic of China3 papers (2023–2024)Jia Kou · Sun Yat-sen University3 papers (2019–2020)Chao Liu · Harbin Medical University3 papers (2021–2024)Chunhui Zhang · Nantong University3 papers (2018–2024)Jun Ma · Air Force Medical University3 papers (2019–2020)Lichuan Wu · Guangxi University2 papers (2023–2025)